An accomplished regulatory life sciences expert, Paul has 30 years’ experience and expert knowledge of the regulatory, commercial, intellectual property, and product liability needs of the pharmaceutical, biotechnology, and medical device sectors on an international and domestic scale.
Prior to joining Keystone, Paul was a partner of two top UK and global firms and spent around a decade in-house advising leading pharmaceutical companies including Smith Kline Beecham.
"At the ‘excellent’ Keystone Law, commercial and regulatory lawyer Paul Ransom joined from Pinsent Masons LLP in May 2015."
Legal 500 2016
"Keystone Law made several hires in 2015, including life sciences expert Paul Ranson, who moved from Pinsent Masons LLP"
Legal 500 2016
“Life sciences specialist Paul Ranson is esteemed for his skills on commercial transactions and also for his magisterial knowledge of the regulatory environment affecting companies in the sector.”
Chambers UK 2015
“Paul Ranson focuses his practice on regulatory matters for a variety of pharmaceutical and biotech firms. He recently advised Alliance Pharma on its acquisition of Opus Group Holdings.”
Chambers UK 2014
Paul was also ranked as one of Super Lawyer’s top rated solicitors.
|2015||Keystone Law | Consultant Solicitor|
|2013-2015||Pinsent Masons | Partner|
|2003-2013||Fasken Martineau | Partner|
|1992-2002||Simmons & Simmons | Partner and Head of Life Sciences|
|1983-1991||Smith Kline Beecham | In-House Legal|
|1980-1983||Merck Sharp and Dohme | In-House Legal|
|1986||Qualified as a Solicitor|
|1976-1979||Practised at the Bar|
|1975||Qualified as a Barrister|